Search Results

HOME > SEARCH > SEARCH RESULTS

Refine by Audience:

Your search for pilot research returned 165 results.

Selected filters: Physicians

Healthcare Provider

Displaying 31 to 40 of 165 records
Sort by: Page: << Prev 1… 2… 3… 4… 5… 6… 7… Next >>

Journal of Nuclear Medicine Supplement Explores Nuclear Cardiology – Nov 20, 2023
A new JNM supplement highlights the exciting new developments and opportunities for nuclear cardiology in the modern era of personalized cardiovascular medicine.
Novel PET Radiotracer Facilitates Early, Noninvasive Detection of Inflammatory Bowel Disease – Nov 14, 2023
A newly developed PET radiotracer can be used to create an inflammation map of the entire gastrointestinal tract, providing detailed information to accurately detect and stage inflammatory bowel disease, according to research published in JNM.
Bone Scans Overstage Prostate Cancer at Initial Staging Compared with PSMA PET – Nov 9, 2023
Bone scans have been found to overstage prostate cancer at initial staging compared to PSMA PET, according to new research published in JNM.
New AI Tool for PET Imaging Allows for High-Quality, Fully Automated Evaluation of Brain Tumors – Oct 17, 2023
A new artificial intelligence tool provides a fully automated, easy-to-use and objective way to detect and evaluate brain tumors, according to new research published in JNM.
PET Imaging Validates Use of Common Cholesterol Drug to Enhance HER2-Targeted Cancer Therapy – Oct 12, 2023
A novel therapeutic approach combining HER2-targeted therapies with the cholesterol-lowering drug lovastatin can reduce the number of cancer treatments required to prevent tumor growth, according to research published in JNM.
Novel Tau PET Tracer Exhibits High Sensitivity and Specificity, Allowing for Earlier Identification of Alzheimers Disease – Sep 28, 2023
A new tau PET radiotracer, F-18 SNFT-1, has been found to be more effective than existing tau PET radiotracers in identifying Alzheimers disease in its earliest stages, according to research published in JNM.
Whole-Body PET/CT Predicts Response to HER2-Targeted Therapy in Metastatic Breast Cancer Patients – Sep 27, 2023
A new imaging agent, Ga-68-ABY-025, can predict early metabolic response to human epidermal growth factor receptor 2 (HER2)-targeted treatment in HER2-positive metastatic breast cancer patients, according to new research published in JNM.
First Three Facilities Accredited in SNMMI/IAC Radiopharmaceutical Therapy Accreditation Program – Sep 25, 2023
SNMMI and the Intersocietal Accreditation Commission are pleased to announce the first three facilities to be awarded the new Radiopharmaceutical Therapy Accreditation.
Nuclear Medicine Treatment Cures Lethal Form of Ovarian Cancer in Preclinical Setting – Sep 18, 2023
A new 225Ac-DOTA-based pre-targeted radioimmunotherapy system has been shown to cure a highly lethal form of advanced intraperitoneal ovarian cancer in a preclinical setting with minimal side effects, according to research published in JNM.
JNM Publishes Consensus Statement on Patient Selection and Appropriate Use of Lu-177 PSMA-617 Radionuclide Therapy – Sep 1, 2023
SNMMI) has issued a new consensus statement to provide standardized guidance for the selection and management of metastatic castrate-resistant prostate cancer (mCRPC) patients being treated with Lu-177 PSMA radionuclide therapy.

Displaying 31 to 40 of 165 records
Page: << Prev 1… 2… 3… 4… 5… 6… 7… Next >>